Nearly two years after BrainsGate submitted its implantable neurostimulation device for FDA premarket approval, an advisory panel for the agency struck a major blow to the Israeli company’s plans.
Novartis is padding out its radioligand portfolio with yet another deal, this time a partnership with Molecular Partners. The duo plans to develop cancer candidates that target tumors for $20 million…
Bristol Myers Squibb is doubling down on Immatics with $150 million upfront to get access to a preclinical bispecific targeting solid tumors.
Generation Bio’s shares were briefly halted Tuesday morning on the release of mouse data that complicated its search for a viable target for hemophilia A to take into the clinic.
Bristol Myers Squibb is paying $150 million up front for global rights to an Immatics biologic drug designed to recruit a patient’s T cells to go after cancer cells. It’s the latest deal in the field…
The American Medical Association, American Hospital Association and other provider groups are suing the Department of Health and Human Services over a small but important detail of how it is…
Virtually all routine dialysis should be available within skilled nursing and long term care facilities. The technology for this type of care exists and training LTC staff on easy to operate, portable dialysis devices should be the norm.
Paul Komenda Dr. Paul Komenda is Chief Medical Officer at Quanta, Professor of Medicine at the University of Manitoba, a fellow of the American Society of Nephrology and has extensive clinical and academic experience. Prior to joining Quanta, Dr. Komenda served on the Scientific Advisory Board of NxStage Medical. Dr. Komenda gained his medical qualification …
CSL Limited makes many of its therapies from donated plasma, which posed a challenge as pandemic lockdowns led to a steep drop in plasma collections. In acquiring Vifor Pharma, CSL not only…
A look at how healthcare organizations are collaborating with Microsoft to enhance patient engagement, accelerate healthcare innovation, improve clinical and operational insights, and more.
